Document 0125
 DOCN  M9580125
 TI    The human immunodeficiency virus.
 DT    9506
 AU    Wheeler DA; Department of Medicine, University of Maryland School of;
       Medicine, Baltimore 21201, USA.
 SO    Cutis. 1995 Feb;55(2):81-3. Unique Identifier : AIDSLINE MED/95246452
 AB    Infection with the human immunodeficiency virus is now a worldwide
       pandemic, transmitted through contact with infected body fluids,
       particularly during heterosexual intercourse. Infection in adults is
       followed by an asymptomatic period that lasts several years, after which
       continued destruction of the immune system renders the individual
       susceptible to multiple opportunistic infections. Antiviral therapy has
       been shown to prolong patient survival. However, viral resistance has
       limited the options available to clinicians. Until a truly effective
       antiviral agent or immune-modulator is developed, efforts to change
       risky sexual practices will remain the most important resource in
       limiting the spread of this infection.
 DE    Female  Human  *HIV/PATHOGENICITY  *HIV Infections/DRUG
       THERAPY/IMMUNOLOGY/PREVENTION & CONTROL  Male  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).